A focused salivary gland infection with attenuated MCMV: An animal model with prevention of pathology associated with systemic MCMV infection

Experimental and Molecular Pathology

Volumn 82, Issue 3, 2007, Pages 269-279

  Pilgrim, Mark J ^a   Kasman, Laura ^a   Grewal, Jasvir ^a   Bruorton, Mary E ^a   Werner, Phil ^a,b   London, Lucille ^a   London, Steven D ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antibodies; MCMV; Mucosa; Mucosal immunity; Rodent; Salivary gland; Spleen and lymph nodes; Viral

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; IMMUNE RESPONSE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; SALIVARY GLAND; SIALOADENITIS; T LYMPHOCYTE;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; MICE; SALIVARY GLAND DISEASES; SPLENIC DISEASES; VIREMIA;

ANIMALIA; HERPESVIRIDAE; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MUS; RODENTIA;

EID: 34247612962     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.12.010     Document Type: Article

References (40)

1. Allan J.E., and Shellam G.R. Genetic control of murine cytomegalovirus infection: virus titers in resistant and susceptible strains of mice. Arch. Virol. 81 1-2 (1984) 139-150
2. Bergmeier L.A., Tao L., Gearing A.J.M., Adams S., and Lehner T. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue. In: Mestecky J. (Ed). Advances in Mucosal Immunology (1995), Plenum Press, New York 1567-1573
3. Britt W.J., and Alford C.A. Cytomegalovirus. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (1996), Lippincott-Raven, Philadelphia 2493-2523
4. Brody A.R., and Craighead J.E. Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J. Infect. Dis. 129 6 (1974) 677-689
5. Castellano G., Hazzard, Madden D.L., and Sever J.L. Comparison of the enzyme-linked immunosorbent assay and the indirect hemagglutination test for detection of antibody to cytomegalovirus. J. Infect. Dis. 136 (1977) S337-S340
6. Cavanaugh V.J., Deng Y., Birkenbach M.P., Slater J.S., and Campbell A.E. Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J. Virol. 77 (2003) 1703-1717
7. Chong K.T., Gould J.J., and Mims C.A. Neutralization of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage. Arch. Virol. 69 2 (1981) 95-104
8. Csencsits K.L., and Pascual D.W. Absence of L-selectin delays mucosal B cell responses in nonintestinal effector tissues. J. Immunol. 169 10 (2002) 5649-5659
9. Csencsits K.L., Jutila M.A., and Pascual D.W. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site. J. Immunol. 163 3 (1999) 1382-1389
10. Csencsits K.L., Walters N., and Pascual D.W. Cutting edge: dichotomy of homing receptor dependence by mucosal effector B cells: alpha(E) versus L-selectin. J. Immunol. 167 5 (2001) 2441-2445
11. Csencsits K.L., Jutila M.A., and Pascual D.W. Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues. Eur. J. Immunol. 32 11 (2002) 3029-3039
12. + T cell clones specific for a mouse cytomegalovirus epitope. Virol. 255 (1999) 40-49
13. + T-cells during murine cytomegalovirus infection in different strains of mice. Virus Res. 36 2-3 (1995) 233-245
14. Ho M. Murine cytomegalovirus. In: Ho M. (Ed). Cytomegalovirus: Biology and Infection (1991), Plenum Medical Book Co., New York 327-353
15. Jackson D.E., Lally E.T., Nakamura M.C., and Montgomery P.C. Migration of IgA-bearing lymphocytes into salivary glands. Cell. Immunol. 63 (1981) 203-209
16. Jordan M.C. Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect. Immun. 21 1 (1978) 275-280
17. Jordan M.C., and Takagi J.L. Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect. Immun. 41 (1983) 841-843
18. Kawabata S., Terao Y., Fujiwara T., Nakagawa I., and Hamada S. Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice. Infect. Immun. 67 (1999) 5863-5868
19. Koszinowski U.H. Molecular aspects of immune recognition of cytomegalovirus. Transplant. Proc. 23 3 Suppl. 3 (1991) 70-74
20. Lee M., Xiao J., Haghjoo E., Zhan X., Abenes G., Tuong T., Dunn W., and Liu F. Murine cytomegalovirus containing a mutation at open reading frame M37 is severely attenuated in growth and virulence in vivo. J. Virol. 74 (2000) 11099-11107
21. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., and Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28 1 (2001) 42-45
22. Leung W.C.T., Hashimoto K., and Hata J. Murine cytomegalovirus infection model in Balb/c mice: 1. Virological and pathological profiles in mice inoculated with various doses. Tokai J. Exper. Clin. Med. 11 (1986) 293-301
23. Lucin P.I., Pavic B., Polic S., Jonjic U., and Koszinowski H. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66 (1992) 1977-1984
24. MacDonald M.R., Li X.-Y., Stenberg R.M., Campbell A.E., and Virgin IV H.W. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant. J. Virol. 72 1 (1998) 442-451
25. Manning W.C., Stoddart C.A., Lagenaur L.A., Abenes G.B., and Mocarski E.S. Cytomegalovirus determinant of replication in salivary glands. J. Virol. 66 (1992) 3794-3802
26. Olver S.D., and Price P. Contrasting phenotypes of liver-infiltrating leucocytes isolated from MCMV-infected BALB/c and C57BL/6 mice. Intern. J. Exper. Path. 79 1 (1998) 33-46
27. Olver S.D., Price P., and Shellam G.R. Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice. Clin. Exper. Immunol. 98 (1994) 375-381
28. Osborn J.E., and Walker D.L. Virulence and attenuation of murine cytomegalovirus. Infect. Immun. 3 (1970) 228-236
29. Ravindranath R.M.H., and Graves M.C. Attenuated murine cytomegalovirus binds to N-acetylglucosamine, and shift to virulence may involve recognition of sialic acids. J. Virol. 64 (1990) 5430-5440
30. Rubin D.H., Kornstein M.J., and Anderson A.O. Reovirus serotype 1 intestinal infection: a novel replicative cycle with ileal disease. J. Virol. 53 (1985) 391-398
31. Shanley J.D., Jordan M.C., and Stevens J.G. Modification by adoptive humoral immunity of murine cytomegalovirus infection. J. Infect. Dis. 143 (1981) 231-237
32. Shanley J.D., Pesanti E.L., and Nugent K.M. The pathogenesis of pneumonitis due to murine cytomegalovirus. J. Infect. Dis. 146 3 (1982) 388-396
33. Shanley J.D., Thrall R.S., and Forman S.J. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice. J. Infect. Dis. 175 (1997) 309-315
34. Tilney N.L. Patterns of lymphatic drainage in the adult laboratory rat. J. Anat. 109 3 (1971) 369-383
35. Tonari Y., and Minamishima Y. Pathogenicity and immunogenicity of temperature-sensitive mutants of murine cytomegalovirus. J. Gen. Virol. 64 (1983) 1983-1990
36. Tucker S.N., Lin K., Stevens S., Scollay R., Bennett M.J., and Olson D.C. Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland. Mol. Ther. 8 (2003) 392-399
37. Tucker S.N., Lin K., Stevens S., Scollay R., Bennett M.J., and Olson D.C. Salivary gland genetic vaccination: a scalable technology for promoting distal mucosal immunity and heightened systemic immune responses. Vaccine 22 (2004) 2500-2504
38. Weekes M.P., Wills M.R., Mynard K., Carmichael A.J., and Sissons J.G. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73 3 (1999) 2099-2108
39. Wu H.-Y., and Russell M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61 (1993) 314-322
40. Ye M., Morello C.S., and Spector D.H. Strong CD8 T-cell responses following co-immunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge. J. Virol. 76 5 (2002) 2100-2112